About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, October 5th, 2017

The QualityStocks
Daily Stock List


International Frontier Resources Corporation (IFRTF)

Stockhouse, Marketwired, MarketWatch, 4-Traders, and Emerging Growth reported on International Frontier Resources Corporation (IFRTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

International Frontier Resources Corporation has a demonstrated record of accomplishment advancing oil and gas projects. The Company, via its Mexican subsidiary, Petro Frontera S.A.P.I de CV and strategic joint ventures (JVs) is advancing the development of petroleum and natural gas assets in Mexico. International Frontier Resources has its corporate headquarters in Calgary, Alberta. The Company lists on the OTC Markets Group’s OTCQB.

In addition, International Frontier Resources (IFR) has projects in Canada and the U.S., including the Northwest Territories and Montana. In 2015, IFR created a JV company - Tonalli Energia - together with Grupo Idesa, one of Mexico’s largest petrochemical companies. IFR and Grupo Idesa are fully aligned; each owns a 50 percent share in Tonalli.

An industry-leading JV combines the strength of Grupo Idesa and IFR. Grupo Idesa is a well-established Mexican petrochemical company. Moreover, IFR brings proven Canadian expertise to Mexico.

Block 24 Tecolutla establishes IFR’s Mexican JV as one of the first operators in Mexico and provides important insights into future rounds. Tecolutla is a very underdeveloped mature field with vast upside potential.

Tonalli has submitted the regulatory applications and documentation that will allow IFR to proceed with the drilling permit and operations at Tecolutla. The Tecolutla Block is in the Tampico-Misantla Basin situated within the state of Veracruz.

The Tecolutla Field is 7.2 square kilometers. It contains an oil reservoir at 2,340 meters or roughly 7,700 feet. The Tecolutla Block is a 60-80m gross pay carbonate reservoir on a structural high with proven oil production. The expectation is that the existing wells at Tecolutla will surpass historic production numbers and peak initial production (IP) rates with the arrival of new recovering techniques, technology, and expertise to be undertaken by Tonalli.

Recently, IFR reported its financial and operating results for the three and six months ended June 30, 2017. It reported a Consolidated Net Loss of $705,070 ($0.01 loss per share) for the six months ended June 30, 2017, versus a Net Loss of $945,145 ($0.01 loss per share) for the six months ended June 30, 2016.

Net Income for the three months ended June 30, 2017 was $73,815 ($0.001 income per share) versus a net loss of $585,360 ($0.01 loss per share) for the quarter ended June 30, 2016.

International Frontier Resources Corporation (IFRTF), closed Thursday's trading session at $0.177, up 4.12%, on 55,688 volume with 73 trades. The average volume for the last 60 days is 10,427 and the stock's 52-week low/high is $0.6978/$1.37.

Mexus Gold US (MXSG)

777 Stocks, SmallCapVoice, AllPennyStocks, Wall Street Reporter, FeedBlitz, OTC Picks, and Stock Guru reported earlier on Mexus Gold US (MXSG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2009, Mexus Gold US is a mining company with holdings in Mexico. Its properties include the fully-owned Santa Elena Mine. This property is 54km NW of Caborca, Mexico. The Santa Elena mine sits in an area that is now undergoing mining by some of the largest mining companies in the world. Mexus Gold US is based in Carson City, Nevada.

The Company has drill results that show a high-grade, multi vein system throughout the Santa Elena mine. Its belief is that the Santa Elena mine has great potential and that a well- funded company will use the significant work already completed to further the project.

Mexus Gold US also owns rights to the Ures property located 80km N of Hermosillo, Mexico. The property contains 6900 acres. It has gold and copper on the property.  

Mexus Gold US entered into a joint venture (JV) agreement with MarMar Holdings of Mexico at its Santa Elena mine. Under the 50/50 JV agreement, MarMar will operate the mine and carry all costs.

In January of this year, Mexus Gold US announced that it determined to acquire the concessions consisting of the San Felix Project. It entered into land surface use agreements and concession purchase agreements for different land parcels that expired under the prior owner’s failure to pay.

Additionally, Mexus announced the execution of an agreement with MarMar Holdings where each company owns a 50 percent share of the San Felix Project and designates MarMar Holdings as the operator of the daily production activities. The San Felix mine in Northern Mexico is a 26,000-plus acre property ready for production planned for 2018.

At the end of July 2017, Mexus Gold US President, Mr. Paul Thompson, and Mr. Marco Martinez, Chief Executive Officer (CEO) of MarMar Holdings, announced that there is a considerable amount of gold in the pregnant pond and on the heap leach pad that is being leached. Mexus geologist Mr. Cesar Lemas confirmed this.

Mr. Lemas’ personal assay lab showed the heap leaching solution, as of 2 weeks prior to the end of July, was producing 1.5grams AU and 18grams AG per m3. Moreover, he noted that the pregnant solution in the pond and heap should yield 145 oz. AU and 1700 oz. AG and the material being leached should yield 400 to 500 oz. AU and 3000 oz. AG with good recoveries. Mr. Lemas also noted at that time that new material being placed on Pad 2 was ranging 1.5 grams to 5 grams per ton AU.

In September, Mexus Gold US along with its JV partner, MarMar Holdings, announced that they produced gold in dore form due to its continuing operation at the Santa Elena mine.

Mr. Marco Martinez, CEO of MarMar Holdings, said that the recovery of gold will be ongoing now that the recovery system is in full working order. Mr. Martinez also stated that the objective is to bring production to 10,000 tons a day by year end.

Mexus Gold US (MXSG), closed Thursday's trading session at $0.047, down 5.05%, on 427,488 volume with 33 trades. The average volume for the last 60 days is 630,296 and the stock's 52-week low/high is $0.025/$0.235.

MEDITE Cancer Diagnostics, Inc. (MDIT)

Wall Street Mover reported earlier on MEDITE Cancer Diagnostics, Inc. (MDIT) and today we report on the Company, here at the QualityStocks Daily Newsletter.

MEDITE Cancer Diagnostics, Inc. is a medical technology company listed on the OTCQB. It specializes in the development, engineering, manufacturing, and marketing of premium medical devices and consumables. These are for detection, risk assessment, and diagnosis of cancer and related disease. The Company has a presence in 80 international markets. MEDITE’s exclusive emphasis is on inventive solutions for cancer diagnostics

MEDITE Cancer Diagnostics is a Delaware registered company consisting of wholly-owned MEDITE GmbH - a Germany-based company with its subsidiaries. The Company previously went by the name CytoCore, Inc. It changed its name to MEDITE Cancer Diagnostics, Inc. in December of 2014. The Company is headquartered in Orlando, Florida.

MEDITE is a foremost developer and manufacturer of unique, high-quality equipment and supplies for histology, pathology, as well as cytology laboratories. Furthermore, the Company involves in the design, development, and commercialization of cost-effective cancer screening systems and Biomarkers to assist in the early detection of cancer.

MEDITE has a complete range of Histology and Cytology lab equipment and supplies. The Company’s focus is on attractive market-and product segments characterized by one or two players. Therefore, there is room for Company market share growth.

MEDITE offers USE33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC15 Duo or Trio; TES99; TES Valida; M530; A550; M380; TST44; COT20 linear staining systems; and RCM9000, ACS720, and TWISTER glass and robotic coverslippers.

MEDITE also provides the SoftPAP device for the collection of cervical cell samples used in the detection of cervical dysplasia, cancer, and human papillomavirus infections. Additionally, it develops the SoftKit device for the self-collection of a sample that can undergo evaluation to provide an assessment of the health of the entire female genital tract. The Company also develops BreastPap breast cancer risk assessment devices, and SureThin and SafePrep products.

MEDITE Cancer Diagnostics announced in May 2017 further restructuring of its organization in Germany. This is to position the Company for revenue growth and profitability.

MEDITE Cancer Diagnostics launched its SureCyte™ C1 fluorogenic instant staining product worldwide at the 29th Annual European Congress of Pathology in Amsterdam, Netherlands, which took place from September 2-5, 2017. SureCyte offers lab efficiencies that enable improved patient care by way of a novel and innovative, self-mounting C1 stain with enhanced imaging when combined with a fluorescent microscope.

MEDITE is initially focusing its launch efforts in the United States, the European Union (EU), and China, taking advantage of existing commercial infrastructure now in place. MEDITE expects to start generating revenues from C1 and related SureCyte instrument sales in Q4 2017. The Company anticipates quarter-over-quarter revenue growth as the rollout broadens.

MEDITE Cancer Diagnostics, Inc. (MDIT), closed Thursday's trading session at $0.426, even for the day, on 20 volume with 1 trade. The average volume for the last 60 days is 1,033 and the stock's 52-week low/high is $0.26/$0.88.

Stina Resources Ltd. (STNUF)

InvestorsHub, Stockhouse, MarketWatch, AwesomePennyStocks, Barron’s, Barchart, and Infomine reported on Stina Resources Ltd. (STNUF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A vanadium resource enterprise, Stina Resources Ltd. is moving towards becoming a fully integrated producer of vanadium and vanadium electrolytes for the vanadium battery storage industry. Its vanadium mineral resources are situated on the Bisoni McKay and Bisoni Rio properties in northern Nevada. Stina Resources’ shares trade on the OTC Markets Group’s OTCQB and the Company is headquartered in Richmond, British Columbia.

Stina Resources is expanding its Nevada vanadium assets through staking more ground in the Nevada Vanadium Belt. The Company is looking to acquire and join strategic technology for the end use of vanadium.

In addition, Stina is now entering the environmental technology industry. It has signed a formal agreement with America Greener Technologies to distribute Soft Wave Technology in Canada.

Soft Wave is a non-chemical water treatment system. It provides several cost-saving, and environmental benefits to businesses, city water infrastructures, industrial and commercial operations, and household consumers. Soft Wave dissolves and suspends minerals in the water. As a result, this prevents scale formation inside the pipes and eliminates prior scaling.

The Bisoni McKay Vanadium Property is a 764 acres (37 claims) vanadium project about 32 miles southeast of Eureka, Nevada. Stina Resources has spent more than $800,000 on drilling and exploration of the Property.

Regarding the Bisoni-Del Rio Property, the Company has recently staked an additional 164 claims immediately to the north. This includes over the Bisoni Vanadium Property, and up to the adjacent Gibillini Vanadium Property. This brings the total Stina Resources land claims in the Nevada Vanadium Belt to 201. It encompasses a total area of 4,115 acres.

At the end of July, Stina Resources announced a new metallurgical testing program on vanadium samples taken from its Bisoni McKay property in Nevada Hazen Research, Inc., based in Boulder, Colorado, was contracted to conduct the new tests. Hazen Research has conducted many metallurgical tests on Bisoni McKay samples dating back to the year 2005.

In late September, Stina Resources announced that it arranged a fully subscribed $2.5 million financing. Proceeds of this financing will be used in developing its vanadium resources on its Bisoni McKay claims and to conduct exploration drilling on its newly acquired Bison Rio claims. In addition, these funds will be for general working capital.

For 2017/2018, Stina Resources’ strategic emphasis includes enhancing shareholder value via exploration, research, and utilizing economical geological exploration technologies on the Bisoni McKay and Bisoni-Del Rio Vanadium Properties. Is strategic emphasis also includes developing technology opportunities in the battery storage industry to join with its world-class vanadium resources.

Stina is continuing to develop the Bisoni McKay and Bisoni-Del Rio vanadium properties to attract alternative energy producers. This includes leading-edge energy storage applications, redox battery manufacturers, and new emerging electronic products.

Stina Resources Ltd. (STNUF), closed Thursday's trading session at $0.208, down 5.02%, on 42,000 volume with 9 trades. The average volume for the last 60 days is 17,020 and the stock's 52-week low/high is $0.0494/$0.2688.

OriginClear, Inc. (OCLN)

MarketWatch reported on OriginClear, Inc. (OCLN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OriginClear, Inc. is a top provider of water treatment solutions. The Company is also the developer of a unique water cleanup technology. Through its wholly-owned subsidiaries, OriginClear provides systems and services to treat water in a wide array of industries. These include municipal, pharmaceutical, semiconductors, industrial, as well as oil & gas. The Company has its wholly-owned subsidiary, Progressive Water Treatment (PWT) of Dallas, Texas. OriginClear is based in Los Angeles, California.

OriginClear invented Electro Water Separation™. This is a cutting-edge high-speed water cleanup technology utilizing multi-stage electrolysis that OriginClear licenses internationally to water treatment equipment manufacturers. Electro Water Separation™ (EWS) is a highly scalable, continuous process. It uses electricity in small, programmed doses to gather up oils and suspended solids. In addition, by way of Advanced Oxidation or AOx, it removes fine, micron-sized suspended solids, and dissolved contaminants, including ammonia.

OriginClear’s mission is to develop Electro Water Separation™ with Advanced Oxidation™ (EWS:AOx™) and accomplish its full recognition as a global industry standard in treating increasingly complex wastewater treatment challenges.

OriginClear has entered into a Master Research Agreement with Florida Atlantic University (FAU) in Boca Raton, Florida. The Agreement establishes a cooperative framework for further scientific research and validation projects concerning the Company’s technology, Electro Water Separation with Advanced Oxidation (EWS:AOx), when applied to landfill leachate treatment.

In August 2017, OriginClear announced that recent testing in the La Kretz Advanced Prototyping Center demonstrated the ability to virtually eliminate the herbicide glyphosate from drinking water by up to 99.3 percent. Glyphosate is the world's leading herbicide.

OriginClear Engineer Ayush Tripathi mixed glyphosate in tap water to a concentration of roughly 300 parts per million (ppm), with 300 ppm salt, and processed it utilizing direct and indirect methods, using lab-scale models of OriginClear's AOx patent-pending Advanced Oxidation Process. The results, as analyzed by a certified laboratory, varied between 95.8 percent and 99.3 percent of glyphosate removal, depending on the method employed.

Furthermore, in September, OriginClear announced that new testing at the La Kretz Advanced Prototyping Center demonstrated real-time removal of glyphosate, the active ingredient in Roundup®, at concentrations of parts per billion. This represents a quantum increase over earlier testing in the range of parts per million.

OriginClear, Inc. (OCLN), closed Thursday's trading session at $0.051, down 0.97%, on 77,214 volume with 15 trades. The average volume for the last 60 days is 142,371 and the stock's 52-week low/high is $0.0306/$0.6475.


The QualityStocks
Company Corner


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA). Today, Marijuana Company of America Inc. closed trading at $0.02745, up 9.36%, on 1,304,612 volume with 126 trades. The stock’s average daily volume over the past 60 days is 6,873,450 and its 52-week low/high is $0.0094/$0.1985.

Marijuana Company of America Inc. (MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA's CEO, founded the first marijuana company ever to trade on a US stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can also be used to produce products that are carbon neutral or even carbon negative, like the longest, strongest natural fiber on earth, building materials that are mold, pest and fire proof, super foods and so much more for additional business opportunities. No part of the plant is left unused and the Company's overall stategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented exponential growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015's $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal and cannabis and industrial hemp sectors. The Company's business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA's strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product "hempSMART Brain," is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience. Disclaimer

Marijuana Company of America Inc. Blog

Marijuana Company of America Inc. News:

Marijuana Company of America, Inc. (MCOA) is “One to Watch”

Marijuana Company of America and Global Hemp Group Retain Space Cowboys to Advise on Hemp Cultivation Project in New Brunswick

Marijuana Company of America Announces Update on Hemp Growing Trials in Canada

Medical Innovation Holdings, Inc. (MIHI)

The QualityStocks Daily Newsletter would like to spotlight Medical Innovation Holdings, Inc. (MIHI). Today, Medical Innovation Holdings, Inc. closed trading at $0.61, up 3.39%, on 81,920 volume with 11 trades. The stock’s average daily volume over the past 60 days is 17,693, and its 52-week low/high is $0.15/$3.99.

Medical Innovation Holdings, Inc. (MIHI), a Colorado-based publicly traded company, owns and operates strategically aligned healthcare service and product companies focused on the delivery of patient care, management services for physician offices, lab services, and pharma; and non-pharma medicines and alternatives to patients and consumers. Healthcare services are delivered and managed through the company's MSO, 3Point Care. 3Point Care uses virtual telemedicine with a unique customized software and hardware platform as a way of bringing quality medical care to rural and medically underserved areas (MUAs) of the country.

3Point Care provides personalized high-tech, high-touch telemedicine encounters that link virtual health specialty doctors with traditional primary physicians and their patients. This approach helps reduce the cost of care while enhancing the quality of care. The company's telemedicine approach is vastly different from other providers who rely on a monthly subscription to opt in the network and then require an encounter fee by the patient each and every time an on-demand physician is utilized. This approach breaks the continuum of care, relies on symptom-based diagnosis, does not accept insurance, and there is no certainty you are dealing with a licensed practitioner. In summation they are not a medical practice but a contract service to deliver virtual care. Because 3Point Care deploys doctors through an actual medical practice, there is no subscription fee. The company works with anyone and everyone that has insurance including Medicare and Medicaid. It works hand and hand with the patient's primary care physician so the continuum of care is always maintained. Part of the integrated software application enables the processing of insurance claims whereby doctors are paid for their services. This allows deductibles to be captured, allowing the patients to take advantage of medical tax deductions.

TeleLifeMd, a multi-disciplinary specialty healthcare practice with strong experience in telemedicine, is the primary deliverer of patient medical care. 3Point care has a unique and exclusive relationship with TeleLifeMD, acting as its management services organization by providing all levels of service that include scheduling, providing telemedicine hardware and software products and support, processing claims, paying all invoices and payroll incurred by TeleLifeMD, as well as any other service required to operate the practice.

BKare Diagnostics, another wholly owned subsidiary of MIHI, is tasked with delivering medical and health-related services such as laboratory testing, diagnostics, and alternative medicines primarily proven nutraceuticals. Its goal is to eventually infuse these products with 100% CBD/Hemp oil and THC-based oils to create new product categories as the law catches up with the cannabis marketplace. The opportunity to offer workable solutions that solve real health problems outside typical big pharma is very exciting for the company. It sees significant revenue opportunities in this space.

MIHI firmly believes the best way to provide access to high-quality medical care is through support and delivery of evidence-based virtual medicine, commonly known as telemedicine. With 80 million people living in rural, medically underserved areas of the nation, the company is poised to fill a glaring void in the healthcare industry by applying cutting-edge technology and time-tested business practices to deliver real-time care. Among the 16 areas of medical specialties available are cardiology, infertility, gastroenterology, pediatrics and obstetrics.

The company serves a number of constituents and stakeholders interested in reducing the cost of health care while simultaneously increasing the quality of care, improving access to health services for millions of people, and bringing value to company shareholders. Its unique platform incorporates every aspect of a telemedicine visit into a single, comprehensive package. Disclaimer

Medical Innovation Holdings, Inc. Company Blog

Medical Innovation Holdings, Inc. News:

Medical Innovation Holdings, Inc. (MIHI) is “One to Watch”

Medical Innovation Holdings, Inc. (MIHI) Announces Recruitment of Industry Veteran as COO

Medical Innovation Holdings (MIHI) CEO Appears in The Big Biz Show

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF)

The QualityStocks Daily Newsletter would like to spotlight Blue Moon Zinc Corp. (BMOOF). Today, Blue Moon Zinc Corp. closed trading at $0.066, up 1.07%, on 36,500 volume with 11 trades. The stock’s average daily volume over the past 60 days is 17,480 and its 52-week low/high is $0.0074/$0.087.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Blue Moon Zinc Corp. (TSX VENTURE: MOON) (OTC: BMOOF), a client of NNW focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California. The publication, titled, "Zinc Shows a Silver Lining as Exchange Stocks Fall to Lowest Level in Decades," highlights companies that are preparing for an increase in zinc demand. To view the full publication, visit: https://www.networknewswire.com/zinc-shows-silver-lining-exchange-stocks-fall-lowest-level-decades/

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF), a mineral exploration company, is focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California. The project sits within Mariposa County, an area of active mines and exploration projects since it was part of the California gold rush era. Blue Moon's 525 acres of mineral rights are assigned to patented and unpatented claims accessible by a gravel road off a nearby highway with main utility lines nearby.

The Blue Moon deposit is one of many located in the Foothills Massive Sulphide Belt in the Sierra Nevada Mountains of California. The property has a long history of exploration and saw small-scale mining during World War II. The current project, to be mined by underground methods, contains an estimated 3.70 million tons with a grade of 8.33% zinc equivalent for approximately 377 million pounds of zinc in the indicated category and another 4.09 million tons with a grade of 7.84% zinc equivalence for approximately 395 pounds of zinc in the inferred category. Significant bi-products of copper, silver and gold are also indicated. The deposit is open at depth and along strike with a high likelihood of expansion.

Current spot prices for zinc is approximately $1.40 per pound, which increases the potential returns of the Blue Moon project.

The historical database shows extensive plans to put the Blue Moon project into production, including several scoping and optimization studies. Past environmental work performed, along with an historical permit and reclamation plan approved for certain underground development, highlights past local county support for the project. These historical studies and permits are expected to help fast track the project's progress as they form an excellent base for the upcoming Preliminary Economic Assessment and later feasibility study.

Among the significant historical studies conducted is a 1998 metallurgical report that shows recovery rates of 95 percent for zinc and lead, 93 percent for copper, 65 percent for silver and 70 percent for gold (http://nnw.fm/U1ckE). The report indicates that simple processing methods will produce premium concentrates with easy separation of the economic minerals.

Blue Moon CEO Patrick McGrath, who has 20 years of experience in financing and executive roles in the junior mining public sector, is joined by a management team with successful track records in leading and participating in significant mineral discoveries with development-stage mining companies. The Blue Moon team also includes a member who permitted and built the Soledad mine in southern California in 2016 and a member who re-started the Mesquite mine in southern California. Local knowledge and know-how is key. The company also plans to engage a recognized third-party engineering firm to prepare a preliminary economic assessment report, expected for release in the first quarter of 2018, to demonstrate the economic viability of the Blue Moon mineral resources. Disclaimer

Blue Moon Zinc Corp. Blog

Blue Moon Zinc Corp. News:

NetworkNewsWire Announces Publication Discussing the Favorable Outlook on Zinc

Blue Moon Announces Updated Mineral Resource Estimate

Blue Moon Provides Corporate Update


The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $0.904, up 7.77%, on 987,689 volume with 703 trades. The stock’s average daily volume over the past 60 days is 148,828 and its 52-week low/high is $0.6171/$0.90.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global (TSX VENTURE: ABCN) (OTCQB: ABCCF), a client of NNW that is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. The publication, titled, "The Generational Growth Opportunity for Canadian Cannabis," discusses a few companies likely to benefit from the global cannabis market's perpetual growth. To view the full publication, visit: https://www.networknewswire.com/generational-growth-opportunity-canadian-cannabis/

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global Blog

ABcann Global News:

NetworkNewsWire Announces Publication Highlighting Public Companies Set to Reap the Rewards of the Cannabis Sector's Continuous Growth

NetworkNewsWire Announces Publication Discussing How Licensed Canadian Cannabis Producers are Preparing for Industry Forecasts

NetworkNewsWire Announces Publication on Investment Opportunities in Canada's Cannabis Market

HighCom Global Security, Inc. (HCGS)

The QualityStocks Daily Newsletter would like to spotlight HighCom Global Security, Inc. (HCGS). Today, HighCom Global Security, Inc. closed trading at $0.024, up 20.00%, on 65,969 volume with 6 trades. The stock’s average daily volume over the past 60 days is 23,278 and its 52-week low/high is $0.006/$0.10.

HighCom Global Security, Inc. (HCGS) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

BlastGard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

HighCom Global Security, Inc. Blog

HighCom Global Security, Inc. News:

HighCom Global Security Provides Q2, FH 2017 Financial Update

HighCom Global Security Issues Update on Product Technology Advances

HighCom Global Security Introduces New CEO and Board of Directors as Part of Globally Focused Restructuring Plan


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(LSTMF) +100.00%


(ONVI) +96.70%


(UMGP) +87.48%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251